<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kuper, Ina</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Remission Can be Achieved in 50% of Early Rheumatoid Arthritis Patients after 25 Weeks in Daily Clinical Practice</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">22-23</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses results of a prospective, descriptive clinical practice-based study [NCT00122382] that was conducted in a cohort of patients with recent onset RA who were DMARD-naïve. The objective of the study was to evaluate whether a step-up DMARD, tight-control approach could produce remission (defined as DAS28 &lt;2.6).</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>